News Room

William R. Koch Joins Plexus Ventures

March 22, 2018

Philadelphia, Pennsylvania - Plexus Ventures is pleased to announce that Bill Koch has joined the Plexus Ventures team as a Director, effective March 1, 2018.

Bill joins us after an accomplished career in worldwide business development with GlaxoSmithKline Consumer Healthcare, during which he led or participated in multiple acquisitions, licenses and divestitures. Bill also developed a divestment “playbook” for identifying, monetizing, and transitioning GSK’s non-strategic assets. Prior to leaving GSK, he was a core member of the integration team responsible for business planning for the GSK-Novartis Consumer joint venture.

Having managed the full life cycle of the transaction process, beyond closing and all the way through transition / integration to the buyer, Bill is keenly aware of the challenges companies face in running an efficient process and selecting the right partner.

Bob Moran, President of Plexus Ventures, commented: “Bill’s hands-on experience in managing projects ranging from single product disposals to complex operational carveouts complements the Plexus team, and positions him to offer our clients practical advice and solutions to successfully implement their divestment program."

Please join us in welcoming Bill to the Plexus Ventures team, which now comprises 13 experienced professional business development consultants and specializes in product divestments, licensing and other sell-side strategic assignments.

If you are contemplating a strategic rationalization of your OTC or life sciences portfolio or would like to learn more about the benefits of doing so, please contact Bill Koch directly.
Direct: +1 267 879 1348

About Plexus Ventures

Now in its 28th year, Plexus Ventures provides strategic advice, business development and alliance management services to clients in the pharmaceutical, consumer healthcare and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in Barcelona, Basel, Beijing, Indianapolis, London, Los Angeles, Milan, Oxford, Philadelphia, Sao Paulo and Tokyo, Plexus Ventures possesses the capabilities to effectively serve clients in North America, South America, Europe and Asia. Plexus Ventures is both well-known and well respected by leading research-based pharmaceutical companies worldwide.